Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RoSIE: Escitalopram in Incident Dialysis Patients
NCT02407821Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Mar 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of escitalopram in major depressive disorder (MDD), sponsored by University Health Network. Started Mar 2015; status: terminated.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02407821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407821.